These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2074054)

  • 1. [Cytoreductive effect of recombinant alfa-interferon in patients with myelofibrosis with myeloid metaplasia].
    Barosi G; Liberato NL; Costa A; Ascari E
    Haematologica; 1990; 75 Suppl 4():48-50. PubMed ID: 2074054
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia.
    Barosi G; Liberato LN; Costa A; Ascari E
    Blut; 1989 Jun; 58(6):271-4. PubMed ID: 2736307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myelofibrosis: response to recombinant human interferon alpha-2a.
    List AF; Kummet TD; Kerr DM
    Leuk Res; 1990; 14(4):321-6. PubMed ID: 2332985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alpha interferon treatment of idiopathic myelofibrosis].
    Cervantes F; Alcorta I; Escoda L; Montserrat E; Rozman C
    Med Clin (Barc); 1993 Oct; 101(13):498-500. PubMed ID: 8231385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha-2b in the treatment of myelofibrosis.
    Furesi L; Laghi Pasini F; Forconi S
    Haematologica; 1990; 75(6):587-9. PubMed ID: 2098307
    [No Abstract]   [Full Text] [Related]  

  • 6. alpha-Interferon in myelofibrosis: a case report.
    Dalla KP; Zeigler ZR; Shadduck RK
    Br J Haematol; 1994 Mar; 86(3):654-6. PubMed ID: 8043450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasia.
    Tefferi A; Elliot MA; Yoon SY; Li CY; Mesa RA; Call TG; Dispenzieri A
    Blood; 2001 Mar; 97(6):1896. PubMed ID: 11263440
    [No Abstract]   [Full Text] [Related]  

  • 8. Pegylated interferon α2a induces complete remission of acute myeloid leukemia in a postessential thrombocythemia myelofibrosis permitting allogenic stem cell transplantation.
    Dagorne A; Douet-Guilbert N; Quintin-Roue I; Guillerm G; Couturier MA; Berthou C; Ianotto JC
    Ann Hematol; 2013 Mar; 92(3):407-9. PubMed ID: 22941306
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of interferon alfa-2 in melanoma. Results of a phase II study in 27 patients].
    Bernengo MG; Doveil GC; Appino A; Sertoli MR; Ardizzoni A; Vidili MG
    G Ital Dermatol Venereol; 1988 Apr; 123(4):185-8. PubMed ID: 3182009
    [No Abstract]   [Full Text] [Related]  

  • 10. Induction of complete remission of acute myeloid leukaemia by pegylated interferon-alpha-2a in a patient with transformed primary myelofibrosis.
    Berneman ZN; Anguille S; Van Marck V; Schroyens WA; Van Tendeloo VF
    Br J Haematol; 2010 Apr; 149(1):152-5. PubMed ID: 19995392
    [No Abstract]   [Full Text] [Related]  

  • 11. [System mastocytosis: presentation of a case evolving into myelofibrosis and no response to interferon alfa 2b].
    de las Nieves M; Poveda F; Queipo de Llano MP; González-Hermoso C
    Sangre (Barc); 1997 Oct; 42(5):430-1. PubMed ID: 9424749
    [No Abstract]   [Full Text] [Related]  

  • 12. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose interferon alfa-2A for the treatment of chronic hepatitis C.
    Watson AR; Bartlomé P
    Ann Pharmacother; 1994 Mar; 28(3):341-2. PubMed ID: 8193424
    [No Abstract]   [Full Text] [Related]  

  • 14. Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.
    Hasselbalch HC; Clausen NT; Jensen BA
    Am J Hematol; 2002 Jun; 70(2):92-9. PubMed ID: 12111781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of myelofibrosis with alfa-interferon.
    McCarthy D; Clark J; Giles F
    Br J Haematol; 1991 Aug; 78(4):590-1. PubMed ID: 1911363
    [No Abstract]   [Full Text] [Related]  

  • 16. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction.
    Barosi G; Ambrosetti A; Buratti A; Finelli C; Liberato NL; Quaglini S; Ricetti MM; Visani G; Tura S; Ascari E
    Leukemia; 1993 Feb; 7(2):200-6. PubMed ID: 8426474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant interferon alpha (rIFN alpha-2b) may retard progression of early primary myelofibrosis.
    Silver RT; Vandris K
    Leukemia; 2009 Jul; 23(7):1366-9. PubMed ID: 19440212
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alpha interferon treatment of chronic myeloproliferative disease associated thrombocytosis].
    Remes K; Pelliniemi TT
    Duodecim; 1993; 109(11):983-9. PubMed ID: 8062671
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant alpha 2 interferon in the treatment of chronic myeloproliferative disorders.
    Bonaccorso R; Teresi M; Gebbia V; Tambone Reyes M; Tinnirello D; Di Marco P; Citarrella P; Mansueto S
    J Chemother; 1989 Jul; 1(4 Suppl):1266-8. PubMed ID: 16312860
    [No Abstract]   [Full Text] [Related]  

  • 20. Agnogenic myeloid metaplasia.
    Block M
    Rev Bras Pesqui Med Biol; 1974; 7(2):185-95. PubMed ID: 4527643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.